Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

ClinicalTrials.gov ID: NCT04660643

Public ClinicalTrials.gov record NCT04660643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for Maintenance of Weight Loss in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-4)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This was a study of tirzepatide in participants with obesity or overweight. The main purpose was to learn more about how tirzepatide maintained body weight loss. The study had two phases: a lead-in phase in which all participants took tirzepatide and a treatment phase in which participants either continued tirzepatide or switched to placebo. The study lasted about 2 years (25 visits).

Study identification

NCT ID
NCT04660643
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
783 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2021 (Actual)
Primary completion
Apr 25, 2023 (Actual)
Completion
May 18, 2023 (Actual)
Last update posted
May 22, 2024

2021 – 2023

United States locations

U.S. sites
48
U.S. states
27
U.S. cities
47
Facility City State ZIP Site status
Cahaba Research Pelham Alabama 35124 —
Scripps Memorial Hospital La Jolla La Jolla California 92037 —
National Research Institute - Wilshire Los Angeles California 90057 —
National Research Institute Panorama City California 91402 —
Artemis Institute for Clinical Research San Diego California 92103 —
University Clinical Investigators, Inc. Tustin California 92780 —
New West Physicians Clinical Research Golden Colorado 80401 —
Optumcare Colorado Springs - Monument Monument Colorado 80132 —
Care Partners Clinical Research Jacksonville Florida 32277 —
South Florida Clinical Research Institute Margate Florida 33063 —
Renstar Medical Research Ocala Florida 34470 —
ForCare Clinical Research Tampa Florida 33613 —
Endocrine Research Solutions, Inc. Roswell Georgia 30076 —
SKY Clinical Research Network Group-Blake Union City Georgia 30291 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
Healthcare Research Network - Chicago Flossmoor Illinois 60422 —
Clinical Investigation Specialists Gurnee Illinois 60031 —
Midwest Institute For Clinical Research Indianapolis Indiana 46260 —
American Health Network of Indiana, LLC - New Albany New Albany Indiana 47150 —
Cotton O'Neil Clinic Topeka Kansas 66606 —
L-MARC Research Center Louisville Kentucky 40213 —
Centennial Medical Group Elkridge Maryland 21075 —
MedStar Health Research Institute (MedStar Physician Based Research Network) Hyattsville Maryland 20782 —
ActivMed Practices and Research Methuen Massachusetts 01844 —
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division Troy Michigan 48098 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Glacier View Research Institute - Endocrinology Kalispell Montana 59901 —
Weill Cornell Medical College New York New York 10065 —
University of North Carolina Medical Center Chapel Hill North Carolina 27514 —
PharmQuest Greensboro North Carolina 27408 —
Wake Forest University Baptist Medical Center (WFUBMC) Winston-Salem North Carolina 27157 —
Lillestol Research Fargo North Dakota 58104 —
Aventiv Research Inc Columbus Ohio 43213 —
Intend Research, LLC Norman Oklahoma 73069 —
Summit Research Network Portland Oregon 97210 —
Capital Area Research, LLC Camp Hill Pennsylvania 17011 —
Tribe Clinical Research, LLC Greenville South Carolina 29607 —
The University of Texas Health Science Center at Houston Bellaire Texas 77401 —
Dallas Diabetes Research Center Dallas Texas 75230 —
North Texas Endocrine Center Dallas Texas 75231 —
Biopharma Informatic, LLC Houston Texas 77043 —
North Hills Family Medicine/North Hills Medical Research North Richland Hills Texas 76180 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Northwest Houston Heart Center Tomball Texas 77375 —
Health Research of Hampton Roads, Inc. Newport News Virginia 23606 —
Capital Clinical Research Center Olympia Washington 98502 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04660643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 22, 2024 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04660643 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →